相关实验视频

Updated: Jul 27, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

校正:整合:对于免疫生物信息学家来说,关于以表位基治疗的福音

Baozeng Sun¹, Junqi Zhang¹, Zhikui Li¹

¹Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China.

Frontiers in immunology

|June 9, 2023

概括

这项研究纠正了先前发表的一篇文章DOI. 校正确保研究人员准确引用和检索科学信息.

科学领域:

免疫学免疫学免疫学
生物医学研究生物医学研究

背景情况:

准确的引用对于科学完整性至关重要.
维护正确的数字物体标识符 (DOI) 确保了研究的可检索性.

研究的目的:

为以前发表的文章提供纠正DOI.
确保科学记录是准确可靠的.

主要方法:

发布了一份纠正通知.
正确的DOI被确定并公布.

主要成果:

文章DOI已经被纠正.
科学界现在可以准确地访问预期的文章.

结论:

准确的DOI对于科学传播至关重要.
这次纠正符合科学出版的标准.

关键词:

生物信息学是一种生物信息学.标志性标志性标志性标志性免疫反应的免疫反应.免疫疗法免疫疗法在的中.整合整合整合整合

更多相关视频

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Immunoprecipitation

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.